Production of human antimicrobial peptide LL-37 in Escherichia coli using a thioredoxin-SUMO dual fusion system

被引:26
作者
Li, Yifeng [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, Prot Prod Core Facil, San Antonio, TX 78229 USA
关键词
Antimicrobial peptide; Dual-tag; Fusion protein; LL-37; SUMO; Thioredoxin; CATHELICIDIN LL-37; RECOMBINANT PRODUCTION; EXPRESSION; PURIFICATION; FAMILY; ROLES;
D O I
10.1016/j.pep.2012.10.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
LL-37 is a human antimicrobial peptide that has been shown to possess multiple functions in host defense. In this report, the peptide was expressed as a fusion with a thioredoxin SUMO dual-tag. Upon SUMO protease mediated cleavage at the SUMO/peptide junction, LL-37 with its native N-terminus was generated. The released peptide was separated from the dual-tag and cleavage enzyme by size-exclusion chromatography. Mass spectrometry analysis proves that the recombinant peptide has a molecular weight as theoretically expected for its native form. The produced peptide displayed antimicrobial activity against Escherichia coli K-12. On average, 2.4 mg peptide was obtained from one liter of bacterial culture. Thus, the described approach provides an effective alternative for producing active recombinant LL-37 with its natural amino acid sequence in E. coli. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 28 条
  • [1] Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli
    Bommarius, B.
    Jenssen, H.
    Elliott, M.
    Kindrachuk, J.
    Pasupuleti, Mukesh
    Gieren, H.
    Jaeger, K-E
    Hancock, R. E. W.
    Kalman, D.
    [J]. PEPTIDES, 2010, 31 (11) : 1957 - 1965
  • [2] Cathelicidin LL-37: A Multitask Antimicrobial Peptide
    Bucki, Robert
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Sokolowski, Wojciech
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2010, 58 (01) : 15 - 25
  • [3] SUMO fusion technology for difficult-to-express proteins
    Butt, TR
    Edavettal, SC
    Hall, JP
    Mattern, MR
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2005, 43 (01) : 1 - 9
  • [4] Cheng X., 2008, World Pat., Patent No. [WO/2008/140582, 2008140582]
  • [5] LL-37, the only human member of the cathelicidin family of antimicrobial peptides
    Durr, Ulrich H. N.
    Sudheendra, U. S.
    Ramamoorthy, Ayyalusamy
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09): : 1408 - 1425
  • [6] Feng Yun, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P634
  • [7] LL-37 as a Therapeutic Target for Late Stage Prostate Cancer
    Hensel, Jonathan A.
    Chanda, Diptiman
    Kumar, Sanjay
    Sawant, Anandi
    Grizzle, William E.
    Siegal, Gene P.
    Ponnazhagan, Selvarangan
    [J]. PROSTATE, 2011, 71 (06) : 659 - 670
  • [8] Recombinant production of antimicrobial peptides in heterologous microbial systems
    Ingham, Aaron B.
    Moore, Robert J.
    [J]. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2007, 47 : 1 - 9
  • [9] High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli
    Krahulec, Jan
    Hyrsova, Marcela
    Pepeliaev, Stanislav
    Jilkova, Jana
    Cerny, Zbynek
    Machalkova, Jana
    [J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2010, 88 (01) : 167 - 175
  • [10] Circulating LL-37 is a biomarker for eczema severity in children
    Leung, T. F.
    Ching, K. W.
    Kong, A. P. S.
    Wong, G. W. K.
    Chan, J. C. N.
    Hon, K. L.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (04) : 518 - 522